Ishida Tatsuhiro | 論文著者

Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima Graduate School

Department of Pharmacokinetics and Biopharmaceutics, Institute of Medical Biosciences, Tokushima University

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Science, Institute of Health Biosciences, The University of Tokushima

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Inst

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Biomedical Sciences, Tokushima University

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Biomedical Sciences, Tokushima University|Department of Cancer Metabolism and Therapy, Subdivision of Biopharmaceutical Sciences, Institute of Bio

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Biomedical Sciences, Tokushima University|Department of Cancer Metabolism and Therapy, Subdivision of Biopharmaceutical Sciences, Institute of Bio

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, The University of Tokushima

Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, 
Institute of Health Biosciences, The University of Tokushima

Department Of Pharmacology University Of Alberta

Department of Pharmacology, University of Alberta

Faculty of Pharmaceutical Sciences, The University of Tokushima

Formulation Research Institute Otsuka Pharmaceutical Co. Ltd.

Formulation Research Institute, Otsuka Pharmaceutical Co., Ltd.

Tokushima University, Japan